(Q33388271)

26 July 2017

title

Kinetic modelling of [11C]flumazenil using data-driven methods (English)

1 reference

26 July 2017

8

Alexander Drzezga

0 references

Till Sprenger

object named as

Till Sprenger

6

0 references

author name string

Isabelle Miederer

1

1 reference

26 July 2017

Sibylle I Ziegler

2

1 reference

26 July 2017

Christoph Liedtke

3

1 reference

26 July 2017

Mary E Spilker

4

1 reference

26 July 2017

Matthias Miederer

5

1 reference

26 July 2017

Klaus J Wagner

7

1 reference

26 July 2017

Henning Boecker

9

1 reference

26 July 2017

publication date

29 November 2008

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

26 July 2017

published in

1 reference

26 July 2017

volume

36

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

659-670

1 reference

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0990-Z

Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0990-Z

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0990-Z

Spectral analysis of dynamic PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0990-Z

Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0990-Z

Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters

21 January 2018

1 reference

12 December 2020

Synthesis of ethyl 8-fluoro-5,6-dihydro5- [11C]methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): A specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography

1 reference

12 December 2020

Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis

1 reference

12 December 2020

Central benzodiazepine receptors in malformations of cortical development: A quantitative study

1 reference

12 December 2020

Assessment of spatial normalization of PET ligand images using ligand-specific templates

1 reference

12 December 2020

Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies

1 reference

12 December 2020

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

12 December 2020

Comparison of methods for analysis of clinical [11C]raclopride studies.

1 reference

12 December 2020

Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography.

1 reference

12 December 2020

Simplified reference tissue model for PET receptor studies.

1 reference

12 December 2020

Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study

1 reference

12 December 2020

Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling

1 reference

12 December 2020

Optimization algorithms and weighting factors for analysis of dynamic PET studies.

1 reference

12 December 2020

A comparison of methods for the separation of [11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans.

1 reference

12 December 2020

1 reference

12 December 2020

Distribution volume ratios without blood sampling from graphical analysis of PET data

1 reference

12 December 2020

Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease

1 reference

12 December 2020

Quantification of brain mu-opioid receptors with [11C]carfentanil: reference-tissue methods

1 reference

12 December 2020

10.1007/S00259-008-0990-Z

Identifiers

DOI

1 reference

26 July 2017

1 reference